Organogenesis Holdings Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 108.53 million compared to USD 116.86 million a year ago. Net income was USD 3.17 million compared to USD 0.215 million a year ago. Basic earnings per share from continuing operations was USD 0.02. Diluted earnings per share from continuing operations was USD 0.02.
For the nine months, sales was USD 333.49 million compared to USD 335.38 million a year ago. Net income was USD 5.51 million compared to USD 8.05 million a year ago. Basic earnings per share from continuing operations was USD 0.04 compared to USD 0.06 a year ago. Diluted earnings per share from continuing operations was USD 0.04 compared to USD 0.06 a year ago.